Nasdaq Inc. (NDAQ) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown strong financial performance and positive analyst sentiment, the lack of significant trading signals, neutral hedge fund and insider activity, and limited positive catalysts suggest holding off for now. The stock's technical indicators and options data do not indicate a compelling entry point at this time.
The MACD is positive and expanding, indicating a bullish trend. RSI is neutral at 65.9, and moving averages are converging, showing no strong directional signal. Key resistance levels are at R1: 88.709 and R2: 90.369, with support at S1: 83.334 and S2: 81.674. The stock is trading near resistance levels, suggesting limited immediate upside.

Strong financial performance in Q4 2025, with revenue up 4.63% YoY, net income up 45.92% YoY, and EPS up 47.54% YoY. Gross margin increased to 57.96%. Analyst sentiment remains positive, with multiple buy ratings and price targets above the current price.
No recent congress trading data or significant hedge fund/insider activity. Stock trend analysis indicates a potential decline of -0.6% in the next day, -2.26% in the next week, and -4.34% in the next month. The stock is trading near resistance levels, limiting immediate upside potential.
Nasdaq Inc. reported strong Q4 2025 financials, with revenue increasing to $2.124 billion (up 4.63% YoY), net income rising to $518 million (up 45.92% YoY), and EPS growing to 0.9 (up 47.54% YoY). Gross margin improved to 57.96%, reflecting operational efficiency.
Analysts remain generally positive on NDAQ. Barclays recently lowered its price target to $114 from $116 but maintained an Overweight rating. TD Cowen adjusted its price target to $105 from $106 with a Buy rating. Keefe Bruyette resumed coverage with a Market Perform rating and a $92 price target. Analysts highlight Nasdaq's potential as a beneficiary of AI and its durable platform, but some express concerns about geopolitical and sector-specific pressures.